Clear Cell Renal Cell Carcinoma 2022–2023

Clear cell renal cell carcinoma is a common tumor in Western countries and an appropriate test subject for new therapies. This Special Issue highlights the most up-to-date research into clear cell renal cell carcinoma from different medical perspectives, including its diagnosis, prognosis, and treat...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Μορφή:	Online
Γλώσσα:	Αγγλικά
Έκδοση:	MDPI - Multidisciplinary Digital Publishing Institute 2024
Θέματα:	TIME (tumor immune microenvironment) synchronous metachronous mRCC (metastatic renal cell carcinoma) PD-L1 immunophenotype imaging renal cell carcinoma biomarker renal mass radiomics radiogenomics circadian rhythm clock genes immunotherapy HIF immune microenvironment tumor immunology immune checkpoint inhibitor cystic renal neoplasm differential diagnosis single-cell RNA-seq cell-of-origin tumor microenvironment stromal cells immune cells novel therapies predictive biomarkers prognostic biomarkers therapeutic monitoring immune checkpoint inhibitors VEGF inhibitors metastatic disease nitric oxide signalling ccRCC cohort study partial nephrectomy radical nephrectomy perioperative outcomes mortality tumor heterogeneity T cell mRCC complement classical pathway “aggressive complement” tumor biomarkers cancer cholesterol LDL HDL VLDL NPC1 TKI indirect comparison Shiny method reconstructed individual patient data disease-free survival adjuvant setting n/a thema EDItEUR::P Mathematics and Science::PB Mathematics::PBW Applied mathematics
Διαθέσιμο Online:	ONIX_20240514_9783725804757_320
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Διαδίκτυο

ONIX_20240514_9783725804757_320

Clear Cell Renal Cell Carcinoma 2022–2023

Διαδίκτυο

Παρόμοια τεκμήρια